Alternatives to MoCA Cognition

All in One Accessibility® is an AI based accessibility tool to enable websites to be accessible among people with hearing or vision impairments, motor impaired, color blind, dyslexia, cognitive & learning impairments, seizure & epileptic, ADHD, & elderly. It installs in just 2 minutes. It reduces the risk of time-consuming accessibility lawsuits by improving accessibility compliance for the standards WCAG 2.0, 2.1, 2.2, ADA, Section 508, European EAA EN 301 549, Canada ACA, California Unruh, Israeli Standard 5568, Australian DDA, UK Equality Act, Ontario AODA, Indian RPD Act, GIGW 3.0, France RGAA, German BITV, Brazilian Inclusion law LBI 13.146/2015, Spain UNE 139803:2012, JIS X 8341, Italian Stanca Act, Switzerland DDA & more. It supports 140+ languages. It is a cornerstone of improving web accessibility through its ease of use for companies of all sizes and with the help of paid add-ons like manual accessibility audit, remediation, PDF accessibility remediation, VPAT/ ACR, white label subscription, and live site translation add-on. Top features of the All in One Accessibility®: - Accessibility statement - Accessibility interface for UI design fixes - Free Accessibility Statement Generator - Voice Navigation - Talk & Type - Libras (Brazilian Portuguese) Sign Language - Dashboard Automatic accessibility score - AI based Image Alternative Text remediation - AI based Text to Speech Screen Reader - Select Screen Reader Voice - Auto-detect language - Keyboard navigation adjustments - Content, Color, Contrast, and Orientation Adjustments - Custom widget color, position, icon size, and type - Dedicated email support

Creyos Health is a platform that is both scientifically validated and trusted by clinicians, designed to be user-friendly for patients, integrating proprietary online tasks with electronic behavioral health questionnaires. This comprehensive, research-supported solution enables healthcare providers to identify cognitive impairments and behavioral health issues while being adaptable, engaging, precise, and eligible for reimbursement. With over three decades of scientific research backing it, Creyos has featured in more than 400 peer-reviewed studies. More than 10,000 healthcare professionals rely on Creyos to assess their patients' cognitive and behavioral health. The platform offers a collection of 12 online cognitive tasks, each requiring just 2-3 minutes to complete, specifically aimed at identifying even subtle cognitive deficits. These tasks evaluate crucial areas such as short-term memory, reasoning skills, concentration, and verbal proficiency. Additionally, the platform incorporates digitized behavioral health assessments that automatically calculate results, delivering rapid insights to healthcare providers. This efficiency allows for timely interventions that can significantly enhance patient care.

Cognistat stands out as a premier cognitive evaluation tool that examines five key areas of cognitive abilities: language, spatial reasoning, memory, calculations, and logical reasoning. Developed at Stanford University, this assessment tool is standardized for use among adolescents, adults, and seniors aged 60 to 84, allowing for broad applicability. It is designed to be administered by healthcare professionals who have received appropriate training. Furthermore, Cognistat has been culturally adapted and validated in various languages through partnerships with esteemed universities, academic institutions, and global clients. Its effectiveness is substantiated by over 400 peer-reviewed scientific studies that document its application in cases involving stroke, dementia, traumatic brain injuries, significant psychiatric conditions, and substance abuse. The Cognistat Assessment System retains the valued features of its traditional paper and pencil version, providing a swift yet thorough evaluation while employing a screening and metric approach to assess cognitive functioning comprehensively. This adaptability and thoroughness make it a vital resource in various clinical settings, enhancing the assessment process for diverse patient populations.

The Cambridge Neuropsychological Test Automated Battery (CANTAB), which was initially created at the University of Cambridge, provides highly accurate and objective assessments of cognitive abilities that are linked to neural networks. With the capability to detect variations in neuropsychological performance, CANTAB encompasses a wide array of tests that evaluate working memory, learning, and executive function, as well as visual, verbal, and episodic memory; attention, information processing, and reaction time; social and emotional recognition, decision-making, and response control. These cognitive evaluations serve as crucial instruments for unraveling the complexities of specific brain functions associated with various disorders and conditions, offering valuable insights into their underlying causes, facilitating the early detection of symptoms, and assessing the impact of interventions aimed at enhancing brain health. By utilizing the CANTAB, researchers and clinicians can better understand cognitive impairments, leading to more effective strategies for treatment and support.

BrainSightAI is an innovative health technology firm that harnesses the power of artificial intelligence and machine learning to transform the field of brain mapping through AI-driven connectomics, allowing for the creation of customized brain maps. The VoxelBox product line employs these AI techniques to produce individualized brain maps tailored to each patient's needs. These advanced tools are specifically designed to facilitate pre-surgical preparation and enhance patient outcomes for those suffering from brain tumors and various neurological issues. Collaborating with top hospitals across the country, BrainSightAI is engaged in clinical trials that explore a range of brain-related ailments such as Alzheimer's disease, brain tumors, psychiatric disorders, Parkinson's disease, and stroke. Committed to pushing the boundaries of brain science, our overarching goal is to improve quality of life by offering state-of-the-art resources that deepen our understanding of the human brain and its complexities. By continually refining our technology and methodologies, we aspire to make significant contributions to the medical community and the lives of patients.

BrainFx has developed interactive digital cognitive assessments that are specifically tailored to uncover aspects of neurofunction that conventional cognitive tests might overlook, thereby assisting health professionals in gaining a clearer understanding of an individual's cognitive state, particularly when it comes to identifying mild to moderate dysfunction. These assessments provide valuable insights that aid in crafting more personalized treatment strategies through activities that reflect real-life situations and functions. By employing an innovative Neurofunctional approach, BrainFx goes beyond traditional cognitive evaluation, recognizing that factors such as psychosocial and physical health, as well as environmental and task-related elements, can significantly impact cognitive performance. This method allows the assessments to be more reflective of real-world scenarios, increasing their complexity and sensitivity. Consequently, BrainFx assessments are better equipped to identify subtle deficits that other testing methods might miss, enhancing the accuracy and effectiveness of cognitive evaluations. As a result, individuals can receive targeted interventions that are informed by a comprehensive understanding of their unique circumstances.

CogniFit stands out as a prominent provider of customized online cognitive training solutions aimed at evaluating and improving a range of cognitive abilities for individuals of all ages. Their platform, which is backed by scientific research, features more than 60 interactive games and mental exercises that focus on enhancing skills such as memory, attention, reasoning, and coordination. Users can start with a complimentary assessment to gain insights into their cognitive strengths and weaknesses, after which they can participate in personalized training programs that aim to bolster specific areas of cognitive function. The resources offered by CogniFit are beneficial not only for individuals looking to enhance their mental capabilities but also for professionals in fields like healthcare, education, and research, who utilize these tools to facilitate cognitive growth and recovery. Track your cognitive performance with daily and weekly score updates, set achievable goals to boost your scores through consistent brain training sessions, and create a structured plan to practice as frequently as needed to achieve your objectives. This comprehensive approach ensures that users can actively engage in their cognitive development journey.

Lumosity is a cognitive enhancement program that aims to improve memory, mental agility, and other skills through enjoyable games. By converting scientific tasks from research settings into interactive challenges, the program focuses on enhancing cognitive abilities such as memory retention, speed of thought, and analytical skills. Users benefit from tailored feedback and insights about their cognitive performance, with daily sessions presenting new and stimulating games to maintain engagement. The platform customizes experiences based on users' specific strengths and areas for improvement, providing a unique learning journey for each individual. With an extensive library of over 50 games developed by experts in neuroscience and game design, Lumosity addresses key cognitive domains including speed, memory, attention, flexibility, problem-solving, language, and mathematics. Its user base has surpassed 100 million individuals globally, showcasing its widespread appeal. Additionally, a randomized study by Lumos Labs revealed that participants who utilized Lumosity for 10 weeks demonstrated greater advancements in various cognitive assessments compared to those in a control group, particularly in areas like working memory and fluid reasoning, underscoring the program's potential effectiveness in brain training.

CAMCI-Research is a versatile set of computerized tasks aimed at evaluating cognitive abilities. This self-paced, computer-based tool enables researchers to customize task protocols for the purpose of gathering data on accuracy and reaction times, which can then be compared against normative benchmarks. The full CAMCI-Research suite comprises nine behavioral tasks that evaluate various cognitive domains, including attention, memory (encompassing verbal, non-verbal, functional, and incidental memory), executive functions, and processing speed. To further enrich the assessment, participants may answer a range of self-report questions aimed at collecting insights into factors that might influence their task performance, such as perceived cognitive decline, alcohol consumption, symptoms of depression, and levels of anxiety. A distinctive feature of this battery is a virtual environment task that explores areas like incidental memory, which are challenging to measure through traditional paper-and-pencil methods. The use of computer-administered tasks guarantees uniformity in both administration and scoring, effectively minimizing variability that could arise from differences between examiners or testing sites. Researchers can thus rely on the consistency and reliability of the results obtained through this comprehensive assessment tool.

Cognigram is an online platform designed to automatically analyze data and produce reports that summarize the outcomes of cognitive tests. Typically, completing the Cognigram assessment requires around 10 to 15 minutes. This tool is aimed at supporting healthcare professionals by providing an objective evaluation of cognitive function for individuals ranging from 6 to 99 years of age. The resulting reports are user-friendly for clinicians and include comparisons to normative data from healthy, age-matched individuals. The assessment process, which takes roughly 15 minutes, evaluates four distinct cognitive domains. Results are computed automatically, ensuring efficiency. The assessment consists of four tests that utilize playing cards to pose straightforward "yes" or "no" questions, with instructions and practice sessions provided for clarity. Furthermore, the Cognigram system can be utilized not only for a one-time assessment but also for monitoring cognitive changes across multiple evaluations, making it a versatile tool in cognitive assessment.

The Herrmann Brain Dominance Instrument (HBDI) is a comprehensive survey consisting of 116 questions that effectively evaluates thinking preferences through four interconnected systems that correspond to the brain's quadrants. Created by Ned Herrmann while he was leading management education at General Electric, this instrument was designed to explore the influence of thought patterns on management and leadership growth. Unlike typical assessments that measure behavior or personality traits, the HBDI offers a unique perspective on an individual's cognitive inclinations, shaping their methods for problem-solving and decision-making processes. Importantly, it does not measure one's abilities, skills, or specific cognitive functions, nor does it evaluate activity in particular brain regions. With over 4 million users across more than 60 countries and available in 16 different languages, the HBDI has established itself as a vital resource for organizations seeking to leverage cognitive diversity. Its widespread use underscores the importance of understanding varied thinking styles in enhancing teamwork and innovation.

Herrmann's Whole Brain Thinking is a scientifically grounded approach that interprets and utilizes the diverse cognitive styles present among individuals, teams, and organizations. By gaining insight into their distinct thinking preferences, individuals are better equipped to identify areas for enhancement, foster effective collaboration, and progress toward their objectives. The implementation of Whole Brain Thinking cultivates improved focus, productivity, and teamwork, facilitating synergy among individuals, teams, and departments to optimize each member's contributions. Moreover, it diminishes unproductive disputes and the risk of groupthink by enabling leaders, managers, and team members to leverage everyone's cognitive styles, allowing for rapid identification of challenges and adaptability in dynamic environments. This methodology not only enhances communication but also accelerates the transfer of knowledge through straightforward integrations, empowering teams to apply Whole Brain Thinking principles to tackle real-world workplace dilemmas effectively. Ultimately, it fosters a more innovative and adaptive organizational culture.

HappyNeuron is an innovative digital tool for cognitive therapy aimed at assisting healthcare professionals in delivering cognitive rehabilitation, stimulation, and remediation. It features an expanding library of 45 customizable exercises that focus on a range of cognitive functions such as executive function, memory, language skills, attention, visual-spatial capabilities, processing speed, and auditory processing. These exercises can be tailored to meet the specific challenges faced by each individual patient. Clinicians can also access printable worksheets, which help to supplement therapy with evidence-based resources. Furthermore, the HappyNeuron Pro version includes features for automatic tracking and reporting of patient progress, streamlining the process for healthcare providers to assess improvements. Notably, the platform accommodates multiple languages, making it accessible for patients to receive treatment in their preferred language. Clinicians have the ability to assign home exercises to patients, thereby increasing the frequency and intensity of therapeutic activities, which may lead to better cognitive health outcomes and overall patient engagement. In doing so, HappyNeuron not only enhances the quality of therapy but also empowers patients to take an active role in their cognitive rehabilitation journey.

The microbiome plays a significant role in various diseases and health issues. Discover how Kaleido is pioneering a unique method to transform the potential of the microbiome into effective patient solutions. Comprising over 30 trillion microbes, the human microbiome includes a diverse array of organisms such as bacteria, viruses, archaea, and fungi that inhabit both the exterior and interior of the human body. In recent years, there has been a remarkable surge in research focusing on the microbiome's influence on human health, linking it to conditions such as cardiovascular disease, cancer, diabetes, Parkinson’s disease, and allergies. This intricate microbial community has been likened to a "newly discovered organ," highlighting its significance. Just as many human organs command substantial investments for therapies that modify physiology, the microbiome represents a largely unexplored territory in the realm of healthcare. Addressing this frontier could unlock new therapeutic avenues and enhance overall health outcomes.

Behavioral health constitutes a crucial yet frequently neglected component of overall wellness. The impact of mental and substance use disorders affects an astonishing 970 million individuals globally, contributing to an economic burden exceeding US $1 trillion each year. In spite of this escalating crisis, advancements in treatment and understanding have not kept pace with other medical fields. Alarmingly, less than half of those suffering from major depression, which is the most prevalent mental health disorder, achieve remission with existing therapies. Increased awareness has sparked a greater demand for services in a system that remains ill-equipped to address the extensive complexities of this need. There exists a significant evidence gap that hinders progress in research and innovation, largely due to the inherent challenges within behavioral health, such as intricate disease causes, a shortage of measurable biomarkers, and fragmented institutional approaches. Even after many years of dedicated research, we remain largely in the dark about how to effectively treat most behavioral health conditions, indicating a critical need for renewed focus and resources in this field. Ultimately, bridging this gap is essential for improving the lives of millions affected by these disorders.

Cognassist serves as a platform focused on neuro-inclusion, aiming to empower every individual with diverse cognitive profiles to succeed. We support organizations in their commitment to neuro-inclusion on a daily basis through our premier cognitive diversity assessments and specialized training on neurodiversity. Our solutions not only help employees thrive but also assist companies in adhering to legal and ethical guidelines. We provide certified training programs that equip teams with the necessary knowledge and skills, enhancing their effectiveness. Our clinically validated cognitive mapping allows for tailored workplace modifications and acknowledges varying preferences for sharing personal information. The neuro-difference dashboard enhances the visibility of neuro-diversity within organizations, fostering a more inclusive environment. For educational institutions, we aid in recognizing the unique needs of students, customizing their learning experiences, reducing expenses, ensuring compliance with Ofsted standards, and improving overall achievement. Our efficient digital cognitive assessments can pinpoint learner needs within just 30 minutes, making it easier to address individual challenges and support diverse learning paths. Ultimately, our mission is to create a world where every cognitive difference is celebrated and leveraged for success.

Innovative technology derived from doctoral studies offers advanced connected care for individuals with dementia. Co-created with input from those living with dementia, DevaWorld features over 15 therapeutic interventions and virtual activities of daily living (ADLs). Our approach emphasizes enhancing human engagement rather than substituting it, encouraging active involvement from both caregivers and patients. The platform includes more than 15 evidence-based therapeutic activities and strategies focused on individual needs, fostering confidence and empowerment among users. Designed as a tranquil and purposeful environment, DevaWorld promotes rich social and environmental interactions that enhance communication and understanding. Built specifically for a residential community that provides continuous memory care, it follows the best practices in dementia therapy. The integration of the caregiver-player dynamic was a fundamental aspect of the design process, as this collaborative experience significantly contributes to uplifting the mood and overall well-being of participants. By prioritizing this joint interaction, DevaWorld aims to create a supportive atmosphere that enriches the lives of both caregivers and those they care for.

Cognitive Apps provides an AI-driven API that seamlessly integrates mental health analytics into a wide array of existing products and services. By examining users' voice or text inputs, the API identifies emotions, moods, and mental health statuses, offering valuable insights such as overall mood assessment, emotion recognition, and tracking of mental health conditions. With an impressive accuracy rate of 87%, the platform requires just a brief 5-second voice sample to conduct swift emotion analysis. This technology is versatile, benefiting numerous industries by enhancing app capabilities, tailoring user experiences, and optimizing UX through real-time emotion detection. The API effectively analyzes data from voice recordings, textual interactions, and physical health metrics, providing a holistic view of mental health that enriches customer data and fosters personalized user experiences. Moreover, by leveraging this innovative approach, businesses can gain deeper insights into user behavior and preferences, ultimately driving better engagement and customer satisfaction.

Amwell's SilverCloud is a comprehensive digital mental health platform featuring more than 30 online behavioral health programs designed to tackle various concerns, such as anxiety, depression, stress, and chronic ailments. These programs, which are interactive and grounded in evidence-based practices, aim to empower users in managing their mental health through tailored content, engaging tools, and supportive methodologies. Available on mobile devices, tablets, and computers, SilverCloud offers a private and adaptable approach to mental health care, enabling users to interact with the resources at their own convenience and speed. This platform is widely regarded by a multitude of health systems, health plans, employers, and educational institutions for its ability to provide effective support on a large scale. Research has shown that nearly 80% of participants experience a reduction in symptoms related to anxiety and depression after engaging with SilverCloud's offerings. Furthermore, the platform includes targeted programs for families, substance use issues, and additional specific needs, highlighting its versatility in addressing diverse mental health challenges. Overall, SilverCloud represents a significant advancement in the accessibility and effectiveness of mental health resources.

Mahalo Health is an integrated digital health platform aimed at expediting the creation of patient-focused digital health solutions and clinical trials. By providing a variety of prebuilt modules, Mahalo facilitates the swift launch of customizable white-label applications that cater to particular therapeutic fields. The platform boasts comprehensive data capabilities, featuring a predictive health engine for forecasting diseases and diagnoses, a behavior modification engine to encourage beneficial patient behaviors, and a notification system that ensures timely communication through push notifications, SMS, or emails. Committed to maintaining high security and compliance standards, Mahalo follows regulations such as HIPAA, GCP, ISO27001, and GDPR. Its extensive range of services encompasses multiple therapeutic areas, including diabetes, cognitive health, cardiovascular issues, musculoskeletal conditions, mental health, oncology, rare diseases, and nonalcoholic steatohepatitis (NASH). Additionally, Mahalo Health empowers healthcare providers with tools to enhance patient engagement and outcomes through its innovative digital solutions.

IntelliSpace Portal 9.0 is an innovative visualization platform encompassing over 70 clinical applications, providing a cohesive solution that enhances speed and efficiency while boosting diagnostic confidence, particularly in the analysis and monitoring of complex cases. As the global population ages, the prevalence of neurodegenerative diseases continues to escalate, necessitating long-term monitoring for patients with neurological disorders, which can often exhibit subtle brain changes that are difficult to identify. To address these challenges, IntelliSpace Portal 9.0 introduces several new and improved neuro applications, including NeuroQuant®¹, LoBi, and CT Brain Perfusion, all designed for swift, objective, and consistent image assessment. Additionally, with a growing focus on pulmonary health, this platform equips you with a comprehensive suite of tools to seamlessly manage pulmonary disease from initial detection through to ongoing follow-up, ultimately aiming to improve patient outcomes. This integration of neuro and pulmonary features positions IntelliSpace Portal 9.0 as a vital resource in modern medical imaging and diagnostics.

Neurab offers a cognitive rehabilitation application specifically designed for individuals with acquired cognitive impairments, featuring exercises that target particular deficits to deliver both restorative and compensatory interventions. The company has developed a device that replaces traditional printed materials, allowing for remote supervision of patients and monitoring of their performance through customizable statistics. Neurab's digital solution includes an online platform and a tablet, offering a variety of exercises that are not only highly customizable but also available in ready-to-use free sessions, particularly beneficial for patients in the post-acute phase of recovery. This innovative device serves as a reliable and adaptable resource for cognitive rehabilitation, supporting independent patients by enabling them to track their performance and progress effectively. Ultimately, Neurab is committed to enhancing the rehabilitation experience through technology that empowers both patients and healthcare providers.

Diagnosis refers to the process of determining what disease or condition is causing a person's symptoms and test results. DDxHub – Differential diagnosis Hub is a system that distinguishes a specific disease or condition from others with similar symptoms and lab results. DDxHub is a concentrator which holds a lot disease descriptions. DDxHub can be useful when you are trying to find the right diagnosis by comparing multiple diagnoses. You can upload your own disease definition to DDxHub repository, and then share it with other DDxHub users worldwide. You will receive disorder descriptions from other DDxHub users in return. Join thousands of healthcare professionals and patients who already love DDxHub’s differential diagnosis, sync, disorders description sharing solution. DDxHub can be used by medical students in clinical therapeutics as an educational resource.

Apollo Medical Imaging Technology is a pioneering software company focused on enhancing medical imaging through innovative image processing solutions tailored for both clinical and research purposes. Their leading product, MIStar, stands out as a cost-effective and user-friendly software suite that encompasses a wide range of advanced features and versatile cross-modality solutions, catering to the needs of clinicians and original equipment manufacturers alike. MIStar efficiently accommodates several imaging modalities, including CT, MR, NM, and PET, and boasts specialized modules such as CT Perfusion for stroke and various tumors, DSC-MRI for stroke analysis, DCE-MRI for tumor assessments, as well as DWI & ADC, and DTI Fiber Tractography. Additionally, it offers NM Renogram Analysis and Image Fusion capabilities, making it a comprehensive tool in medical imaging. The software also ensures seamless data management and image input via DICOM networking, complemented by an intuitive clinical database that facilitates easy anonymization and archiving of sensitive patient data. This combination of features positions MIStar as a crucial asset in modern medical imaging practices.

The Do-IT Profiler is an online platform focused on screening and assessing neurodiversity, assisting both organizations and individuals in recognizing the strengths and difficulties linked to various neurodivergent conditions, including ADHD, dyslexia, autism, dyscalculia, and dyspraxia. It features customized profilers tailored to different situations, such as the Neurodiversity Profiler + for adults who want to gain insights into their cognitive profiles, the Neurodiversity Workplace Profiler intended for employees looking to enhance their job performance, and the Children's Profiler which caters to parents or guardians of kids aged 7 to 16. Each of these profilers generates a unique report that includes personalized recommendations, useful support tools, and resources aimed at leveraging strengths while addressing challenges effectively. Beyond profiling, Do-IT Profiler provides neurodiversity training courses and consultancy services designed to foster inclusivity and enhance the well-being of individuals within organizations. Ultimately, the platform serves as a comprehensive resource for those seeking to navigate the complexities of neurodiversity in various aspects of life.

NeuroQ stands out as a premier software for brain imaging analysis, delivering a robust diagnostic resource applicable across various modalities and clinical scenarios. This comprehensive tool supports an array of imaging techniques, including FDG, Amyloid, SPECT, DaTscan, and Epilepsy, thereby enhancing diagnostic precision in differentiating between various conditions. As one of the most prevalent quantitative instruments utilized in the differential diagnosis of dementia, NeuroQ transcends simple visual evaluations by offering crucial, objective diagnostic insights. It efficiently assesses metabolic levels across over 240 predefined brain regions, contrasting them with a normative database to quantify the extent of abnormalities and their statistical significance. Designed to assist in the evaluation of human brain scans, NeuroQ meticulously quantifies mean pixel values within standardized areas of interest and allows for detailed comparisons with other brain images, ultimately contributing to better patient outcomes. This innovative software is essential for clinicians seeking reliable data to inform their diagnostic processes and treatment decisions.

Enhance patient care by using the only objective, quantitative arterial analysis software validated through histology and based on CTA technology. This innovative tool employs ground-truth histological data to reveal the origins of myocardial ischemia, helping to assess risks for heart attacks and strokes. These critical events are often driven by unstable, non-obstructive plaques within the arteries that remain undetected and unaddressed. Traditional non-invasive diagnostic methods fall short, as they cannot penetrate deep into the arterial walls where heart disease begins to manifest. Elucid is leveraging advanced scientific imaging alongside artificial intelligence to facilitate rapid, reliable, and non-invasive diagnoses, ultimately leading to tailored treatment strategies for cardiovascular conditions and improved patient outcomes. With this histology-validated software, you can evaluate plaque composition and determine the risks of heart attacks and strokes with unmatched precision. This comprehensive, objective visualization of arterial health empowers healthcare providers to devise customized treatment approaches well before a patient arrives for hospital care, significantly enhancing the quality of healthcare delivery.

Founded in 2016, Infervision stands at the forefront of AI-driven medical technology, dedicated to enhancing multidisciplinary healthcare services and operations through innovative artificial intelligence solutions. Their advanced AI offerings are designed to assist healthcare professionals across a spectrum of tasks, including disease screening, diagnosis, intervention, treatment, patient management, and medical research. Among their array of solutions, InferRead CT Lung specializes in detecting lung nodules from chest CT scans, while InferRead DR Chest focuses on identifying chest abnormalities via X-ray imaging. Moreover, InferRead CT Coronary is tailored for recognizing coronary artery stenosis during coronary CT angiography, and InferRead CT Stroke is adept at triaging hemorrhages from brain CT scans. The company also provides InferRead CT Bone for spotting chest fractures in CT images and InferRead CT Pneumonia for diagnosing and managing pneumonia cases. Beyond these, their offerings extend to InferOperate, which facilitates 3D reconstruction for thoracic, liver, and urological surgical procedures, and InferCare, a tool designed for effective patient management and image follow-up. Additionally, InferScholar acts as an AI-enhanced resource for medical research, further solidifying Infervision's commitment to transforming healthcare through AI technology. This comprehensive suite of solutions positions Infervision as a pivotal player in the evolution of medical practices.

Dystech, an Australian enterprise, focuses on enhancing the process of reading assessments and dyslexia screenings through cutting-edge, AI-based solutions. Their platform, known as Dyscover, facilitates online evaluations across a range of reading concepts such as phonics, fluency, and phonological awareness, making it adaptable for both in-person and remote use. This tool is extensively utilized by professionals including speech pathologists, educators, teaching assistants, and tutors who work with children aged five and older. Upon completion of each assessment, Dyscover generates immediate and detailed reports, removing the necessity for manual grading and promoting a data-informed strategy for literacy interventions. Moreover, the AI assistant Dystutor provides tailored recommendations and lesson plans that are based on the assessment findings, thereby aiding educators in meeting the specific needs of their students. Dystech aims to revolutionize the accessibility and effectiveness of reading assessments, ultimately striving to enhance literacy outcomes for learners. By leveraging technology, they are transforming the landscape of educational support for those facing reading challenges.

Identify issues related to plant emergence to inform replanting choices. Monitor for weeds both before they sprout and throughout the growing season to optimize herbicide use. Recognize signs of nutrient deficiencies to evaluate changes in crop health over time. Detect crop pests and diseases to facilitate targeted pesticide applications and safeguard yields. Pinpoint equipment failures that may lead to emergence issues and reduced yield. Assess hydration levels to determine if crops are suffering from drought conditions or overwatering. Utilize our sorting interface and crop progression maps to enhance equipment guidance from planting to harvest. Add long-term value by detecting drainage and tiling issues before they can impact yield negatively. Harness AI technology to accurately identify precise areas of crop stress, enabling more effective scouting and providing reassurance to growers. The innovative AI cognitive decision-making engine has already analyzed vast amounts of crop imaging data across various seasons, demonstrating its intelligence and continuous improvement. With this advancement, farmers can make more informed decisions to enhance their agricultural practices, ultimately leading to better productivity and sustainability.

The integration of artificial intelligence is set to revolutionize the field of healthcare diagnosis. By leveraging AI and predictive analytics, we can achieve early detection of diseases and enhance diagnostic accuracy. Our cloud-based AI platform aims to make healthcare more affordable and accessible for everyone. Endimension Technology, a healthcare AI startup fostered at IIT Bombay, specializes in developing advanced algorithms that identify abnormalities and diseases from medical imaging. Our team comprises experts in machine learning, software engineering, and medical professionals from esteemed institutions. We are dedicated to creating AI-driven healthcare solutions that will significantly minimize the incidence of patient misdiagnosis. Furthermore, our technology is designed to alleviate the workload of radiologists while simultaneously improving the speed at which patients receive their results, ultimately leading to better healthcare outcomes. By harnessing the power of AI, we envision a future where diagnostic processes are more efficient and reliable.

Inactivity is a significant contributor to various lifestyle diseases, such as diabetes and stress-related conditions. These health issues often arise from a combination of poor dietary choices and insufficient physical activity, which can lead to obesity. Moreover, engaging in unhealthy habits like smoking increases the risk of developing serious illnesses, including cancer and cardiovascular diseases, as well as complications such as blood clots linked to elevated cholesterol levels. Stress, another prevalent lifestyle disease, can impact individuals regardless of their employment status, manifesting as a feeling of inadequacy in meeting personal or societal expectations. Furthermore, loneliness, which is relatively common in Nordic countries, can exacerbate feelings of isolation and may lead to depression, highlighting the importance of social connections for mental well-being. It is crucial to address these interconnected issues to promote a healthier lifestyle and overall quality of life.

Cogmi is an innovative tool that leverages artificial intelligence to monitor mental efficiency, aiding both individuals and teams in synchronizing their tasks with inherent cognitive patterns to boost productivity and enhance overall well-being. This platform provides immediate evaluations of mental efficiency, monitoring aspects such as focus, memory, and energy fluctuations throughout the day. Users benefit from customized scheduling suggestions, insights powered by AI, and assessments of burnout risk, all aimed at maximizing performance while safeguarding against burnout. For individuals, Cogmi is accessible at no cost, while teams can take advantage of tailored dashboards, advanced analytics driven by AI, and coaching from cognitive experts. By promoting sustainable productivity, Cogmi encourages users to align their work habits with their brain's natural rhythms rather than fighting against them. It was developed to tackle the common problems of determining the best times to work and addressing issues related to fragmented concentration, ultimately striving to offer a more intelligent approach to understanding and improving mental efficiency. In doing so, Cogmi empowers users to harness their cognitive strengths for better outcomes in both professional and personal endeavors.

Aiforia provides advanced deep learning and cloud-based solutions to pathologists and researchers in both preclinical and clinical laboratories, enhancing their capabilities in image analysis and workflow efficiency. By enabling scientists to discover new disease biomarkers and assisting R&D professionals in accelerating the market introduction of innovative drugs, Aiforia plays a crucial role in improving cancer diagnostic accuracy while revolutionizing healthcare from the initial discovery phase through to diagnosis. For clinical pathology laboratories seeking to boost efficiency and elevate the precision of their diagnoses, the Aiforia Clinical Suites present a comprehensive range of AI-driven diagnostic tools, intelligent visualization, quality control, and automated pre- and post-screening functionalities. We are in the process of developing specialized Suites targeting some of the most common cancers globally and have achieved CE-IVD certification for our AI solutions in lung and breast cancer, positioning us as a leader in diagnostic innovation. Our commitment to enhancing patient outcomes through technology underscores the transformative potential of our offerings in the healthcare sector.

Oncoustics is pioneering the development and application of innovative, patented AI technologies aimed at providing low-cost, non-invasive surveillance, diagnostics, and treatment monitoring for diseases that currently face significant clinical challenges. The company has developed a range of specialized applications focused on various diseases and anatomical structures that are compatible with any point-of-care ultrasound device, allowing physicians, nurses, and technicians to operate them as essential tools in a primary care setting without requiring image analysis. By leveraging AI, Oncoustics transforms affordable point-of-care ultrasound machines into robust diagnostic instruments capable of facilitating quick and economical identification and monitoring of conditions affecting the liver, prostate, kidney, breast, and thyroid. The multidisciplinary team behind Oncoustics consists of professionals with expertise in AI, signal processing, radiology, hepatology, digital health, and ultrasound, ensuring a comprehensive approach to healthcare innovation. The emphasis on cost-effective point-of-care diagnostics and surveillance significantly enhances patient outcomes through timely detection and consistent monitoring, which are crucial for effective disease management and better overall health. As such, Oncoustics is not only addressing immediate healthcare needs but is also setting the stage for a transformation in how we approach disease management in the future.

Delving into the realm of the mind for everyone, Explorer stands out as an affordable and effective neurofeedback system designed for professionals in various fields such as Neuroscience, Psychology, Medicine, Engineering, and Information Technology. Our goal is to democratize brain research, making it accessible to all. The platform seamlessly integrates machine learning and automated pattern analysis, empowering both seasoned researchers and new graduates to investigate neural activity with ease. This opens up vast opportunities for brain exploration and understanding. Central to this innovation are Brain-Computer Interfaces (BCIs), which are sophisticated devices that interpret brain signals, allowing software to analyze the data and execute commands, whether it’s for controlling robotic arms, managing video games, or assessing emotional and cognitive states, including sleep stages. Resembling a lightweight, wireless headband, these devices have the remarkable ability to interpret thoughts in real time, paving the way for groundbreaking advancements in brain research and technology. With such potential, the future of neuroscience is brighter than ever.

Recite Me Accessibility Toolbar, one of the most popular WCAG & ADA Compliant Toolbars. Users can customize and alter the design of your website to suit their needs. Perfect for users with visual, cognitive, and mobility impairments in addition to other disabilities. Recite Me also offers a free Accessibility Checker that can be used to measure the accessibility of your website. You can detect specific accessibility issues on your website, fix them and improve its accessibility.

Cleerly is a pioneering digital health organization that is revolutionizing how healthcare professionals manage heart disease. Our innovative clinical technologies are designed to enable clinicians to detect and accurately characterize atherosclerosis at an earlier stage, allowing for the development of customized and potentially life-saving treatment strategies for patients throughout their healthcare journey. Rather than relying on indirect indicators like risk factors or symptoms, we focus on measuring atherosclerosis directly, which is the accumulation of plaque in the arteries of the heart. By utilizing our AI-driven digital care pathways, we provide streamlined, rapid, and precise diagnostics and reporting that cater to the needs of all stakeholders, leading to enhanced clinical and financial results. Cleerly equips healthcare providers to transcend conventional assessments of heart disease by thoroughly analyzing, characterizing, and quantifying various plaque types. This advanced approach enables clinicians to better assess a patient's likelihood of experiencing a heart attack and to formulate effective treatment plans that aim to enhance overall heart health, ultimately fostering improved patient outcomes and quality of care.

InCrowd Interview is an innovative qualitative research solution that leverages technology to enable swift and economical research involving a broader spectrum of healthcare professionals. With the ability to schedule same-day interviews, projects that traditionally required weeks or even longer can now be finalized within just a few days. The methodology encompasses finding verified participants from a dedicated panel, coordinating expert interviews, recording those sessions, and securely storing both recordings and transcripts on the platform. This solution enhances accessibility by offering a user-friendly experience that effectively removes barriers for healthcare professionals, simplifying the engagement process for both researchers and HCPs. The streamlined technology optimizes the workflow by automating participant identification, sending invitations, and scheduling both participants and moderators, all through a single, efficient execution. Furthermore, it is crafted with compliance at the forefront, enhancing communication and providing secure in-platform storage for all transcripts, thus ensuring that researchers can focus on gaining insights without worrying about data management. Overall, InCrowd Interview transforms the qualitative research landscape, making it more efficient and user-oriented.

CNS Vital Signs stands at the forefront of creating and advancing tools and technologies for the assessment of neurocognitive and behavioral health. We equip healthcare professionals and researchers with state-of-the-art technology that enhances their ability to evaluate and manage neurocognitive and behavioral conditions effectively. Our comprehensive platform features a wide range of computerized testing designed to assess, track, and address issues related to neurocognitive and behavioral health. Clinicians rely on CNS Vital Signs for a quick and efficient evaluation of a patient's neurocognitive function. This assessment tool is well-established and often covered by insurance, making it a preferred choice for patients exhibiting neurocognitive or behavioral challenges. With a user base of over 10,000 clinicians and researchers across 52 countries, CNS Vital Signs is widely recognized in the field. Our platform not only serves hospitals and healthcare providers but also empowers researchers to advance the understanding of neurocognitive conditions and improve patient outcomes.

Talktrac® offers a unified platform for private practice therapists to record client attendance, monitor progress on treatment objectives, and assess the effectiveness of therapies for individuals across all age groups who receive speech-language, occupational, and physical therapy services. Similarly, for school-based therapists, educators, and administrators, Talktrac® serves as a centralized hub to manage student attendance and evaluate the success of implemented interventions and IEP objectives for those receiving relevant therapy sessions or educational support. For staffing agencies, Talktrac® acts as an innovative and user-friendly resource that enables Speech-Language Pathologists, Occupational Therapists, and Physical Therapists to easily document clients' progress toward specific goals, attendance records, and the efficacy of therapeutic interventions. Additionally, Talktrac® supports higher education institutions by providing the necessary tools to facilitate the instruction of programs related to Speech-Language Pathology and related fields, enhancing the learning experience for future professionals. This comprehensive approach not only streamlines documentation but also fosters better communication among all stakeholders involved in the therapeutic process.

We assess health beyond traditional healthcare environments to gain a deeper insight into the burden of diseases. This holistic perspective on patient wellness reveals new business avenues by introducing innovative metrics for understanding disease and patient health. By cultivating a patient-focused comprehension of how diseases affect daily functioning, we can engage both physicians and payers more effectively while enhancing patient support initiatives. Furthermore, we aim to develop sophisticated algorithms that can forecast disease onset and its progression or regression, as well as pinpoint critical moments for intervention. Utilize actual digital data to advocate for the advantages of your offerings. Our technology-driven service facilitates real-world research that integrates unique, day-to-day behavioral information, thereby benefiting clinical, medical affairs, and commercial divisions, all while utilizing Evidation's virtual research site, Achievement. With adaptable study designs, strategies for device integration, and streamlined protocol management, we ensure efficient study operations. Additionally, we offer the flexibility for sponsorship either by us or your organization, allowing for tailored collaboration.

Digital programs designed to foster enduring behavioral changes among vulnerable groups can effectively eradicate persistent, health-diminishing habits. Discover how to permanently overcome detrimental behaviors that contribute to chronic diseases. These online cognitive training solutions help mitigate the expensive behavioral health risks faced by employees. Many chronic illnesses stem from six predominant unhealthy habits that are notoriously difficult to overcome due to their emotional underpinnings, which often resist traditional behavior modification strategies. Our cognitive training initiatives target and dismantle the emotional and psychological factors that sustain these harmful habits. Unlike conventional methods, these interventions replicate the experience of personal coaching at a significantly lower price point. The programs include pre-recorded instructional videos led by expert trainers, along with engaging quizzes and multimedia resources, all accessible through a companion app. Participants receive systematic guidance to reach their objectives through a combination of “live” video coaching and interactive content, enhanced by timely notifications to keep them on track. This comprehensive approach ensures that individuals not only understand the changes needed but also have the tools and support to sustain them over time.

Brainsfirst is an innovative platform that leverages neuroscience to assess talent through engaging game-based evaluations, measuring cognitive abilities in a manner that is both scientifically sound and free from bias. Central to their offering is the NeurOlympics, which consists of four interactive games aimed at evaluating a range of cognitive functions, including processing speed, action speed, accuracy, mental flexibility, and attention span. Each assessment yields over 1,500 data points for participants, creating a detailed cognitive profile that helps match individuals with appropriate roles and career trajectories. By incorporating established skills taxonomies like ESCO and O*NET, Brainsfirst ensures that the insights gained are relevant across various sectors and job roles. In addition to enhancing recruitment processes, Brainsfirst’s solutions facilitate early talent identification, improve team dynamics, support career mobility, and even assist in identifying sports talent. This multifaceted approach positions Brainsfirst as a leader in talent assessment and development, bridging the gap between cognitive science and practical application in the workplace.

Specialty and rare diseases often encompass patient populations that are not clearly defined, including individuals who remain undiagnosed or face misdiagnoses, along with healthcare providers who may lack knowledge about these conditions and their various manifestations, resulting in treatment pathways that are poorly understood. IPM.ai operates as an Insights-as-a-Service (IaaS) firm, dedicated to empowering leading life sciences organizations to gain deeper insights into patient care and enhance the quality of life for those affected through the development, clinical research, and commercialization of therapeutic solutions. By predicting market size, analyzing the competitive landscape, and estimating potential return on investment, companies can optimize their commercialization strategies. Additionally, the platform identifies undiagnosed and misdiagnosed individuals who could benefit from early disease interception and therapeutic measures. It employs statistical models to gauge the prevalence of specific diseases within certain patient populations at any given moment. Furthermore, IPM.ai helps pinpoint physicians who are adept at diagnosing and treating these ideal patients, while also influencing other healthcare providers to enhance overall patient outcomes. This comprehensive approach ultimately aims to bridge the gap in understanding and addressing the needs of those with rare diseases.